FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to new compounds described by formula 
in which radical and symbol values are specified in the patent claim, and their pharmaceutically acceptable salts. These compounds inhibit tompomyosine-related kinases (Trk), and can find application in treating a malignant growth, such as breast cancer, rectal cancer and prostate cancer. Also, the invention relates to a method for producing these compounds, a based pharmaceutical composition and to methods of application thereof.
EFFECT: preparation of the pharmaceutical composition which can find application in treating a malignant growth.
18 cl, 134 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CHEMICAL COMPOUNDS | 2006 |
|
RU2405780C2 |
| PYRAZOLE DERIVATIVES AND USE THEREOF AS RECEPTOR TYROSINE KINASE INHIBITORS | 2004 |
|
RU2413727C2 |
| CHEMICAL COMPOUNDS-759 | 2008 |
|
RU2481348C2 |
| 2-PHENYLAMINOPYRIMIDINE DERIVATIVES AS LEUCINE-RICH REPEAT KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON'S DISEASE | 2012 |
|
RU2661197C2 |
| COMPOUNDS AND COMPOSITIONS AS PROTEIN TYROSINE KINASE INHIBITORS | 2006 |
|
RU2386630C2 |
| FLUORINE-18 AND CARBON-11 LABELED RADIOLIGANDS FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING FOR LRRK2 | 2012 |
|
RU2650641C2 |
| AMINOPYRAZOLOPYRIMIDINE COMPOUND USED AS INHIBITOR OF TYROSINE KINASE RECEPTOR OF NEUROTROPHIC FACTOR | 2017 |
|
RU2764523C2 |
| MACROCYCLIC COMPOUNDS AS TRK KINASE INHIBITORS | 2019 |
|
RU2778294C2 |
| DERIVATIVES OF HYDRAZONE-PYRAOLE AND MEDICAL APPLICATION THEIROF | 2002 |
|
RU2332996C2 |
| ISOINDOLE COMPOUNDS AND USE THEREOF AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATION FACTORS | 2005 |
|
RU2420517C2 |
